Prior work considers effects of prescribing restrictions on opioid use but not upstream implications for pharmaceutical marketing activities, despite the inordinate role many believe marketing played in the crisis. Our study proposes a stylized model of pharmaceutical payments and investigates...

Prior work considers effects of prescribing restrictions on opioid use but not upstream implications for pharmaceutical marketing activities, despite the inordinate role many believe marketing played in the crisis. Our study proposes a stylized model of pharmaceutical payments and investigates...

One of the more contentious policy changes in the past decade in the United States involves the decisions by several state legislatures and the FDA to permit sales of emergency contraception on a non-prescription basis. We took advantage of a set of natural experiments to estimate the impact of...